乳腺癌骨转移的诊断与治疗现状(2)
[7]Koizumi M,Yonese J,Fukui I,et al.The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone[J].BJU Int,2001,87(4):348-351.
[8]Kabayashi T, Gabazza EC, Taguchi O,et al.Type I collagen metabolites as tumor markers in patients with lung carcinoma [J].Cancer,1999,85(9):1951-1957.
[9]吕青,肖融.骨转移生化指标在乳腺癌诊治中的应用[J].中国普外基础与临床杂志,2004,11(1):29-31.
[10]成向阳,吴哲凡,杨德康,等.ICTP诊断肺癌骨转移的初步研究[J].癌症,2000,19(2):166-167.
[11]孙达春,张爱华,李小虎,等.骨转移瘤患者骨密度和血清骨代谢指标变化的临床研究[J].肿瘤研究与临床,2003,15(1):16-18.
[12]于世英.恶性肿瘤骨转移的诊断与治疗[M].北京：中国协和医科大学出版社，2006.161-162.
[13]邹萍,蔡宗萍.153Sm-EDTMP治疗1 024例骨转移癌疗效分析[J].重庆医学,2005,3(48):1140-1141.
[14]Wang RF,Zhang CL,Zhu SL,et al.Comparative study of 153 Sm-EDTMP with pamidronate disodium in the treatment of patients with painful metastatic bone cancer[J].Med Princ Pract(MPP),2003,12(2):97-101.
[15]Zgiammarile F,Mognetti T,Resche I,et al.Bone pain palliation with 89Sr in cancer patients with bone metastases [J].Q J Nucled,2001,45(1):78-83.
[16]邓钢，何仕诚，滕皋军，等.经皮椎体成形术治疗脊柱恶性肿瘤[J].介入放射学杂志,2005,1(43):261-264.
[17]王振堂,林琳，赫强，等.椎体成形术的临床应用[J].中华放射学杂志,2004,3(812):1301-1303.
[18]Yoneda T.Cellular and Molocular Mechanisms of Breast and Prostate Cancer Metastasis to Bone[J].European Journal of Cancer，1998，34(2)：204.
[19]MundyGR.Metastasis to bone：causes，consequences and therapeutic
opportunities[J].Nat Rev Cancer，2002，2(8)：584.
(收稿日期：2008-02-02), http://www.100md.com(赵 坚 刘 健)
[8]Kabayashi T, Gabazza EC, Taguchi O,et al.Type I collagen metabolites as tumor markers in patients with lung carcinoma [J].Cancer,1999,85(9):1951-1957.
[9]吕青,肖融.骨转移生化指标在乳腺癌诊治中的应用[J].中国普外基础与临床杂志,2004,11(1):29-31.
[10]成向阳,吴哲凡,杨德康,等.ICTP诊断肺癌骨转移的初步研究[J].癌症,2000,19(2):166-167.
[11]孙达春,张爱华,李小虎,等.骨转移瘤患者骨密度和血清骨代谢指标变化的临床研究[J].肿瘤研究与临床,2003,15(1):16-18.
[12]于世英.恶性肿瘤骨转移的诊断与治疗[M].北京：中国协和医科大学出版社，2006.161-162.
[13]邹萍,蔡宗萍.153Sm-EDTMP治疗1 024例骨转移癌疗效分析[J].重庆医学,2005,3(48):1140-1141.
[14]Wang RF,Zhang CL,Zhu SL,et al.Comparative study of 153 Sm-EDTMP with pamidronate disodium in the treatment of patients with painful metastatic bone cancer[J].Med Princ Pract(MPP),2003,12(2):97-101.
[15]Zgiammarile F,Mognetti T,Resche I,et al.Bone pain palliation with 89Sr in cancer patients with bone metastases [J].Q J Nucled,2001,45(1):78-83.
[16]邓钢，何仕诚，滕皋军，等.经皮椎体成形术治疗脊柱恶性肿瘤[J].介入放射学杂志,2005,1(43):261-264.
[17]王振堂,林琳，赫强，等.椎体成形术的临床应用[J].中华放射学杂志,2004,3(812):1301-1303.
[18]Yoneda T.Cellular and Molocular Mechanisms of Breast and Prostate Cancer Metastasis to Bone[J].European Journal of Cancer，1998，34(2)：204.
[19]MundyGR.Metastasis to bone：causes，consequences and therapeutic
opportunities[J].Nat Rev Cancer，2002，2(8)：584.
(收稿日期：2008-02-02), http://www.100md.com(赵 坚 刘 健)